TrialHuman vaccines & immunotherapeutics2022

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India.

Nijalingappa K Kalappanavar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.